Abstract
The lipidosterolic extract from the saw palmettoSerenoa repens (LSESr) is commonly used for medical treatment of benign prostatic hypertrophia due to its ability to inhibit 5α-reductase which permits the conversion of testosterone to dihydrotestosterone, the active androgen on prostate cell proliferation. However, the complete action mechanism of LSESr is still unknown. Several lines of evidence suggest that, in addition to inhibition of 5α-reductase, it may interfere with the action of prolactin (PRL). We therefore investigated a possible interference of this plant extract with another hormone that controls prostate gland growth, PRL. As the action mechanism of PRL is now fully documented in Chinese hamster ovary cells expressing the PRL receptor, we have conducted our experiments on these cells. In this study, using electrophysiological (whole-cell recording and single-channel recording), microspectrofluorimetric and biochemical techniques, we show that LSESr (1–30 µg/ml) reduced the basal activity of a K+ channel and of protein kinase C (PKC) in CHO cells. In addition, pretreatment of the cells with 1–10 µg/ml LSESr for 6–36 h abolished the effects of PRL on [Ca2+]i, K+ conductance and PKC. LSESr may block PRL-induced prostate growth by inhibiting several steps of PRL receptor signal transduction. LSESr may also be useful for diseases implicating PRL.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Ann Biochem 72:248–254;1976.
Briley M, Carilla E, Roger A, Couzinier J. A new treatment of prostatic hyperplasia, Permixon, has antiandrogen effects at two complementary levels. New Trends Androl Sci 1:1;1985.
Brooks JR, Berman C, Glitzer MS, Gordon LR, Primka RL, Reynolds GF, Rasmusson GH. Effect of a new 5α-reductase inhibitor on size, histologic characteristics and androgen concentrations of the canine prostate. Prostate 3:35–42;1982.
Buckley AR, Montgomery DW, Kipler R, Putman CW, Zukoski CF, Gout PW, Beeb CT, Russel DM. Prolactin stimulation of ornithine decarboxylase and mitogenesis in Nb2 node lymphoma cells: the role of protein kinase C and calcium mobilization. Immunopharmacology 12:37–51;1986.
Caffrey JM, Brown AM, Schneider MD. Mitogens and oncogens can block the induction of specific voltage-gated ion channels. Science 236:570–573;1987.
Chen C, Corbley MJ, Roberts TM, Hess P. Voltage-sensitive calcium channels in normal and transformed 3T3 fibroblasts. Science 239:1024–1026;1988.
Djiane J, Daniel N, Bignon C, Paly J, Waters M, Vacher P, Dufy B. Prolactin receptor and signal transduction to milk protein genes. Proc Soc Exp Biol Med 206:299–303;1994.
Dorfman RI, Kincl FA. Relative potency of various steroids in anabolic-androgenic assay using the castrated rat. Endocrinology 72:259–266;1963.
Farnsworth WE, Brown JR. Testosterone metabolism in the prostate. Natl Cancer Inst Monogr 12:323–329;1963.
Farnsworth WE, Slaunwhite WR Jr, Sharma M, Oseko F, Brown JR, Gonder MJ, Cartagena R. Interaction of prolactin and testosterone in the human prostate. Urol Res 9:79–88;1981.
Gasser F, Mulsant P, Gillois M. Long-term multiplication of the Chinese hamster ovary (CHO) cell line in a serum-free medium. In Vitro Cell Dev Biol 21:588–592;1985.
Grayhack JT, Bunce PL, Kearns JW, Scott WW. Influence of the pituitary on prostatic response to androgen in the rat. Bull Johns Hopkins Hosp 96:154–163;1954.
Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440–3450;1985.
Hafiez AA, Bartke A, Lloyd CW. The role of prolactin in the regulation of testis function: The synergistic effects of prolactin and luteinising hormone on the incorporation of [I-14C] acetate into testosterone and cholesterol by testes from hypophysectomised rats in vitro. J Endocrinol 53:223–230;1972.
Huggins C, Russel PS. Quantitative effects of hypophysectomy on testis and prostate of dogs. Endocrinology 39:1–7;1946.
Ko KWS, Cook HW, Vance DE. Reduction of phosphatidylcholine turnover in Nb2 node lymphoma cell line after prolactin treatment. J Biol Chem 261:7846–7852;1986.
Lesueur L, Edery M, Paly J, Clark J, Kelly P, Djiane J. Prolactin stimulates milk protein promoter in CHO cells cotransfected with prolactin receptor cDNA. Mol Cell Endocrinol 71:7–12;1990.
Lesueur L, Edery M, Ali S, Paly J, Kelly PA, Djiane J. Comparison of long and short forms of the prolactin receptor on prolactin-induced milk protein gene transcription. Proc Natl Acad Sci USA 88:824–828;1991.
Lews RS, Cahalan MD. The plasticity of ion channels: parallels between the nervous and immune systems. Trends Neurosci 11:214–218;1988.
Lostroh AJ, Li CH. Stimulation of the sex accessories of hypophysectomised male rats by non-gonadotrophic hormones of the pituitary gland. Acta Endocrinol (Copenh) 25:1–16;1957.
Mollard P, Guérineau N, Audin J, Dufy B. Measurement of Ca2+ transients using simultaneous dual-emission microspectrofluorimetry and electrophysiology in individual pituitary cells. Biochem Biophys Res Commun 164:1045–1052;1989.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63;1983.
Murphy LJ, Di Mattia GE, Friesen HG. Role of calcium in prolactin-stimulated c-myc gene expression and mitosis in NB2 lymphoma cells. Endocrinology 122:2476–2485;1988.
Negro-Vilar A, Saad WA, McCann SM. Evidence for a role of prolactin in prostate and seminal vesicle growth in immature male rats. Endocrinology 100:729–737;1977.
Neuzil E, Cousse H. Le Palmier-scie Serenoa repens. Aspects pharmacologiques. Utilisation thérapeutique actuelle. Bull Soc Pharm Bordeaux 132:142–163;1994.
Nilius B, Wohlrab W. Potassium channels and regulation of proliferation of human melanoma cells. J Physiol 445:537–548;1992.
Parant MR, Vial HJ. Rapid and serial determination of protein kinase C activity and of the associated [3H] PDBU binding using a 96-well microtiter plate and a cell harvester. Anal Biochem 184:283–290;1990.
Piomelli D, Volterra A, Dale N, Siegelbaum SA, Kandel ER, Schwartz JH, Belardetti F. Lipoxygenase metabolites of arachidonic acid as second messengers for presynaptic inhibition of Aplysia sensory cells. Nature 328:38–43;1987.
Prevarskaya N, Skryma R, Vacher P, Bignon C, Daniel N, Djiane J, Dufy B. Early effects of PRL on ion conductances in CHO cells expressing PRL receptor. Am J Physiol 267:C554-C562;1994.
Prins GS. Prolactin influence on cytosol and nuclear androgen receptors in the ventral, dorsal and lateral lobes of the rat prostate. Endocrinology 120:1457–1464;1987.
Ragab A, Ragab-Thomas JMF, Delhon A, Tisne-Versaille J, Gassama-Diagne A, Fauvel J, Cousinier JP, Chap H, Douste-Blazy L. Effect of Permixon® (Sereprosta® in Spain) on phospholipase A2 activity and on arachidonic acid metabolism in cultured prostatic cells. In: Di Silverio F, Steg A, eds. New Trends in Bladder Cancer Chemotherapy. New Trends in BPH Etiopathogenesis. Roma, Acta Medica, 1:293–296;1988.
Rui H, Djeu JY, Evans GA, Kelly PA, Farrar WL. Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation. J Biol Chem 267:24076–24081;1992.
Skryma R, Prevarskaya N, Vacher P, Dufy B. Voltage-dependent ionic conductances in Chinese hamster ovary (CHO) cells. Am J Physiol 267:C544-C553;1994.
Smith C, Assimos D, Lee C, Grayhack JT. Metabolic action of prolactin in regressing prostate: independent of androgen action. Prostate 6:49–55;1985.
Syms AJ, Harper ME, Griffiths K. The effect of prolactin on human BPH epithelial cell proliferation. Prostate 6:145–153;1985.
Too CKL, Walker A, Murphy P, Cragoe EJ Jr, Jacobs HK Jr, Friesen HG. Identification of amiloride-sensitive Na+/H+ exchange in rat Nb2 node lymphoma cells. Stimulation by 12-0-tetradecanolyl-phorbol-13-acetate. Endocrinology 121:1503–1511;1987.
Too CKL, Cragoe EJ, Friesen HG. Amiloridesensitive Na+/H+ exchange in rat Nb2 node lymphoma cells. Stimulation by prolactin and other mitogenes. Endocrinology 121:1512–1520;1987.
Vacher P, Mac Kenzie J, Dufy B. Arachidonic acid affects membrane ionic conductances of GH3 pituitary cells. Am J Physiol 257:E203-E211;1989.
Vacher P, Tran Van Chuoi M, Paly J, Djiane J, Dufy B. Short term effect of prolactin on intracellular calcium in Chinese hamster ovary cells stably transfected with prolactin receptor complementary deoxyribonucleic acid. Endocrinology 134:1213–1218;1994.
Wegman EA, Young JA, Cook DI. A 23-pS Ca2+-activated K+ channel in MCF-7 human breast carcinoma cells: An apparent correlation of channel incidence with the rate of cell proliferation. Pflügers Arch 417:562–570;1991.
Wenderoth UK, George FW, Wilson JD. The effect of a 5α-reductase inhibitor on androgenmediated growth of the dog prostate. Endocrinology 113:569–573;1983.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vacher, P., Prevarskaya, N., Skryma, R. et al. The lipidosterolic extract fromSerenoa repens interferes with prolactin receptor signal transduction. J Biomed Sci 2, 357–365 (1995). https://doi.org/10.1007/BF02255223
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02255223